Bayer Schering Pharma appoints Andreas Fibig as chairman of the board

3 August 2008

Bayer Schering Pharma, a business unit of Germany's Bayer AG, has appointed Andreas Fibig as chairman of the board, effective September 1. Mr Fibig is currently a senior vice president at Pfizer. Also joining the board from October 1 is Bernd Metzner, current head of finance at Bayer Italy. Dr Metzner will take responsibility for central administration and organization at the subsidiary. Current chairman, Arthur Higgins, and current CAO head, Werner Baumann, will focus on the roles they hold at Bayer HealthCare.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory



Companies featured in this story

More ones to watch >




Today's issue

Company Spotlight